(19)
(11) EP 0 998 284 A1

(12)

(43) Date of publication:
10.05.2000 Bulletin 2000/19

(21) Application number: 98932144.3

(22) Date of filing: 02.06.1998
(51) International Patent Classification (IPC)7A61K 31/44
(86) International application number:
PCT/EP9803/478
(87) International publication number:
WO 9855/122 (10.12.1998 Gazette 1998/49)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
RO SI

(30) Priority: 05.06.1997 GB 9711683
18.06.1997 GB 9712851

(71) Applicants:
  • SMITHKLINE BEECHAM PLC
    Brentford,Middlesex TW8 9EP (GB)
  • SMITHKLINE BEECHAM CORPORATION
    PhiladelphiaPennsylvania 19101 (US)

(72) Inventors:
  • PATEL, JaiSmithKline Beecham Pharmaceuticals
    Collegeville, PA 19426-0989 (US)
  • ROSS, HamishSmithKline Beecham Pharmaceuticals
    Collegeville, PA 19426-0989 (US)
  • PRICE, RobinSmithKline Beecham Pharmaceuticals
    HarlowEssex CM19 5AW (GB)
  • GRANETT, Jeffrey, RogerSmithKline Beecham
    Box 5089Collegeville, PA 19426-0989 (US)
  • WRAY, Paul Nigel
    Manor Royal,West Sussex, RH10 2QJ (GB)

(74) Representative: Rutter, Keith, Dr. et al
SmithKline Beecham plcCorporate Intellectual Property,Two New Horizons Court
Brentford, Middlesex TW8 9EP
Brentford, Middlesex TW8 9EP (GB)

   


(54) COMPOSITION COMPRISING 5-[4-[2-(N-METHYL-N-(2-PYRIDYL)AMINO)ETHOXY]BENZYL]THIAZOLIDINE-2,4-DIONE